Omega Healthcare Investors’ (OHI) “Overweight” Rating Reiterated at Wells Fargo & Company

Omega Healthcare Investors (NYSE:OHI)‘s stock had its “overweight” rating restated by investment analysts at Wells Fargo & Company in a research note issued on Tuesday, Benzinga reports. They presently have a $43.00 price objective on the real estate investment trust’s stock, up from their previous price objective of $40.00. Wells Fargo & Company‘s price target points to a potential upside of 7.39% from the company’s current price.

OHI has been the subject of a number of other research reports. Scotiabank increased their price objective on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “sector perform” rating in a research note on Monday, August 26th. Truist Financial raised their price target on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “hold” rating in a research note on Wednesday, September 4th. Finally, Mizuho downgraded Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and increased their price objective for the stock from $34.00 to $35.00 in a report on Thursday, July 25th. Eight research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Omega Healthcare Investors presently has an average rating of “Hold” and a consensus price target of $35.78.

Omega Healthcare Investors Stock Down 0.9 %

Shares of OHI opened at $40.04 on Tuesday. The firm has a market cap of $9.89 billion, a P/E ratio of 36.07, a P/E/G ratio of 1.32 and a beta of 1.00. The stock has a 50 day simple moving average of $38.95 and a two-hundred day simple moving average of $34.51. The company has a debt-to-equity ratio of 1.19, a current ratio of 5.79 and a quick ratio of 5.79. Omega Healthcare Investors has a 1 year low of $27.53 and a 1 year high of $41.53.

Omega Healthcare Investors (NYSE:OHI) last issued its earnings results on Thursday, August 1st. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.65 by ($0.20). The firm had revenue of $252.70 million during the quarter, compared to analysts’ expectations of $205.92 million. Omega Healthcare Investors had a return on equity of 8.61% and a net margin of 33.52%. The firm’s quarterly revenue was up 17.5% compared to the same quarter last year. During the same period in the prior year, the company earned $0.74 EPS. On average, analysts forecast that Omega Healthcare Investors will post 2.69 earnings per share for the current fiscal year.

Insider Activity

In other news, COO Daniel J. Booth sold 56,725 shares of Omega Healthcare Investors stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the transaction, the chief operating officer now directly owns 100,000 shares of the company’s stock, valued at approximately $4,025,000. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In other Omega Healthcare Investors news, CFO Robert O. Stephenson sold 22,542 shares of Omega Healthcare Investors stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.19, for a total value of $905,962.98. Following the sale, the chief financial officer now owns 183,076 shares of the company’s stock, valued at approximately $7,357,824.44. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, COO Daniel J. Booth sold 56,725 shares of the business’s stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the transaction, the chief operating officer now directly owns 100,000 shares in the company, valued at approximately $4,025,000. The disclosure for this sale can be found here. Insiders own 1.37% of the company’s stock.

Institutional Trading of Omega Healthcare Investors

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Hennion & Walsh Asset Management Inc. raised its holdings in Omega Healthcare Investors by 96.7% during the 1st quarter. Hennion & Walsh Asset Management Inc. now owns 21,799 shares of the real estate investment trust’s stock valued at $690,000 after buying an additional 10,714 shares during the period. Slagle Financial LLC grew its position in shares of Omega Healthcare Investors by 102.1% during the 4th quarter. Slagle Financial LLC now owns 94,586 shares of the real estate investment trust’s stock worth $2,900,000 after buying an additional 47,785 shares in the last quarter. Private Advisor Group LLC grew its position in shares of Omega Healthcare Investors by 6.6% during the 1st quarter. Private Advisor Group LLC now owns 28,772 shares of the real estate investment trust’s stock worth $911,000 after buying an additional 1,783 shares in the last quarter. Park Avenue Securities LLC grew its position in shares of Omega Healthcare Investors by 5.7% during the 1st quarter. Park Avenue Securities LLC now owns 10,066 shares of the real estate investment trust’s stock worth $319,000 after buying an additional 544 shares in the last quarter. Finally, HighPoint Advisor Group LLC bought a new position in shares of Omega Healthcare Investors during the 4th quarter worth $758,000. Hedge funds and other institutional investors own 65.25% of the company’s stock.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.